UBS reiterated its Buy rating on Priceline Group Inc (NASDAQ: PCLN) after the travel services company reported a solid earnings report, with beat across the
board, and faster than expected growth in its one quarter forward commentary.
Analyst Eric Sheridan noted that Priceline has consistently exceeded competitors on an organic basis and currently books roughly
double the number of room nights per year versus Expedia Inc (NASDAQ: EXPE). Further, Priceline's results appeared resilient against a backdrop of
macro-related and travel safety concerns.
Analyst Commentary
“We believe Priceline presents a compelling risk/reward for investors looking for reliable growth and steady execution,”
Sheridan wrote in a note.
Related Link: Turning
Your Vacation Into A Stock Portfolio
Sheridan pointed out industry wide online
travel penetration remains relatively low and Priceline (via Booking.com and Agoda.com) is well positioned to capture the
additional share due to its strong international presence.
“[M]gmt commentary about alleviation of pressure (in forward quarters) on the RoI compression in performance advertising could
(in our view) cause surprises to the upside on profitability in 2H '17 and 2018,” Sheridan continued.
Quarter, In Review: Postives, Negatives
Among the positives in the fourth quarter, the analyst liked better than expected room night growth of 31 percent and bookings
growth of 26 percent. Further, the first-quarter guidance for room nights and bookings growth well above consensus estimates.
Among the negatives, first quarter EBITDA guidance was below UBS estimate of $550 million–$580 million. The quarter also saw
merchant take rate falling about 600bps.
At last check, shares of Priceline
had climbed 6.61 percent to $1,739.83 after setting a new 52-week high of $1,745.63. Sheridan raised his price target to $1,870
from $1,750.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.